NCT06195319View on ClinicalTrials.gov

Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

March 27, 2024

Study Completion Date

March 27, 2024

Conditions
AbsorptionMetabolismExcretion
Interventions
DRUG

Simufilam

100 mg of \[14C\]-simufilam

Trial Locations (1)

53704

Fortrea, Madison

Sponsors
All Listed Sponsors
lead

Cassava Sciences, Inc.

INDUSTRY

NCT06195319 - Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects | Biotech Hunter | Biotech Hunter